Glass half empty or half full?

Image: edshunnybunny.files.wordpress.com

It's been a crazy month. News that I cannot yet go public with, a son in Afghanistan, a dog with a tumour and a father hospitalised. That's the half empty glass.

Half full - I had a film crew interview me yesterday, filmed at my sister's place as she has much more room than I...and she does not own a big-ass dog who wants to lick the face off strangers.

My son has some trying times ahead, his first duty is life-risking, a task that he performs alone, save for a sniper who will be close-by. I have spoken with him, the fear in his voice reaching across thousands of miles. Fuck, I'm so proud of him.

My dog, Benn, a 10 year old cross Boxer/Rhodesian Ridgeback is going through the wars himself at present. His tumour [malignant] has returned and increased in size over the past few weeks. Sadly, the PDSA cannot operate and remove it this time... but there is some hope. They have told me they may be able to 'scoop' some away, buying him more time. First, he has to rid himself of a skin infection. Anti-biotics and a solution to bathe the infected area for two weeks. Poor guy is sitting next to me now, looking pathetic as he has a lamp-shade type collar around his neck.

My dad, he was hospitalised a few days ago. Angina seems to be the problem. They are keeping him in over the weekend because they cannot seem to understand why he is getting pain and why his spray does not seem to work when an attack comes on.

The news I cannot speak of will probably be public over the coming days or weeks. I'll write about it then.

Gadzooks, wait for one bus and a whole bunch come at once, eh?

On the plus side:

Yesterday I was interviewed and filmed as part of an award I'm picking up next year in LA. I even had to wear make-up!

My book may be a little late in being published, it's been tough to edit whilst all of the 'half empty' incidents have been hanging around. It is looking very professional with the help and guidance of my editor.

Benn needs to walk now...you ever walked a four legged lamp over a field?

Back soon

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

Hey, Addleshaw Goddard Llp

Why do you keep coming back to my blog on a daily basis?

Are you waiting for some sort of announcement?

It ain't gonna happen.

Some words for you to ponder on regarding disclosure from your client, GlaxoSmithKline:

‎"Real journalism consists of what someone doesn't want published, all the rest is public relations." - George Orwell

Have a nice day.


Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

Seroxat - Why the withdrawal issue concerned GSK.

One would have thought upon learning that there was a withdrawal issue with one of their drugs, GSK would have pulled out all the stops to help those taking their drug, Seroxat.

Not according to an internal memo.

Glaxo, it seemed, were more concerned how news of a withdrawal issue with Seroxat would affect their sales for their once blockbuster drug.

Take a good look at the image above. The dollar sign with a near bulging bag shows how withdrawal [they call it discontinuation] was a major issue that could have affected sales. The "money-bag" memo can be seen here

You will note that GSK started to defend the withdrawal issue when Eli Lilly, their competitors, raised the issue that Seroxat had a withdrawal problem.

Glaxo write:

Discontinuation events are not a major clinical issue, but are being used as a commercial smokescreen by Lilly in an attempt to retain market share.

The memo to the GSK salesforce team also stresses:

'Discontinuation symptoms' is the preferred term for describing symptoms which may occur when an SSRi is discontinued.

Terminology such as 'withdrawal symptoms' should be avoided as it implies dependence.

Evidence that has been sealed in American courts show that Glaxo knew about the withdrawal issues of Seroxat many years ago but did not alert the medicines regulators or the public. In the meantime, many people suffered because they did not disclose this.

Glaxo have made many out of court settlements in the US because of this evidence. As part of the settlement agreement, the evidence remains sealed and away from public eye.

If I were an employee of the MHRA or FDA I'd be asking for this evidence because I would feel that I had a duty to safeguard public health. I'd ask when they knew about this problem and why it took so long to inform the authorities about it.

This is fraud, plain and simple.

Here's Karen Barth Menzies, Attorney from the US, speaking about GlaxoSmithKline's suppression of Seroxat withdrawal issues.

The scientific data, she says, showed anywhere between 50 and 80% of the patients will have trouble actually stopping the drug.



ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

GlaxoSmithKline's Lawyers - UK SEROXAT LITIGATION AND THE UK PRESS.

It would appear, through my blog statistics, that Addleshaw Goddard, GlaxoSmithKline's lawyers, just can't keep off my blog. Fleet street, it would seem, are also taking an interest.

Good.

Here's some documents for you all to browse.

Here is a PDF that I sent to the MHRA some years ago. It is patients speaking out because they believe the have been affected by severe Seroxat withdrawal. The MHRA did nothing about it. DOWNLOAD

Here is a 74 page document that GlaxoSmithKline previously sealed. The British press should read through it, the revelations are startling to say the least. - DOWNLOAD

The most interesting, and one that Addleshaw Goddard should find interesting, is this one. A nice internal document from GSK that proudly boasts, "ALL SSRi's ARE NOT THE SAME." - DOWNLOAD

If any of the above haven't convinced you, then maybe the following will? It's another internal document from GSK - This time playing down the withdrawal issues assoociated with Seroxat. - DOWNLOAD

Enjoy reading.

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

FOR DAN

‎"Courage is a resistance to fear, not absence of fear." I am immensely proud of you and your platoon Dan.

Remember that fear and courage are brothers.

I will be with you at all times.

I love you.

Dad

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

UK SEROXAT GROUP ACTION

It appears that information has been leaked to the press regarding the UK Seroxat litigation.


May I remind all of the claimants that you cannot discuss the action without the permission of every claimant in the Group, but that the litigation is ongoing but that in any event as a Trial Judge has been appointed and a trial date fixed this is sub-judice (pronounced sub-jewdisay) and again you are not allowed to comment.

Thanks.

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

Baum Hedlund Present Poster Presentation at the Selling Sickness Conference in Amsterdam

Confidential documents obtained in antidepressant litigation in the United States and released into the public domain have revealed pharmaceutical industry misconduct, including exposure of hidden risks and overblown efficacy, selective reporting of efficacy and safety, conflicts of interests and rampant ghostwriting of medical journal articles for marketing purposes. [Source]

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

FCUK GSK

Shirt in post.

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

THE SIDE EFFECTS OF COMMON PSYCHIATRIC DRUGS

Those good folk over at the Citizens Commission on Human Rights have issued a downloadable PDF report on the side effects of common psychiatric drugs.The report includes information on drug regulatory agency warnings, studies and other reports that may not appear in the packaging information for the drugs.

DOWNLOAD

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

ABC NEWS WANTS YOUR STORIES REGARDING ANTIPSYCHOTICS

Image: onlinemediacultist.com

ABC News in the US are looking for stories from people. Here's the blurb:

Are You in the Foster System and Have Been Prescribed Antipsychotics?
"World News" Wants to Hear Personal Stories From Youth and Workers

Are you in the foster care system? Have you been prescribed antipsychotic medications? Do you feel like you have been unfairly given these medicines in order to control you and not because of an actual mental illness? Are you an employee in the foster care system and feel as though psychiatrists or case workers you work with too routinely give psychotropic medicine to youth in their care?

If so, ABC News would like to hear from you.

Please give us details below, including contact information, and a "World News" producer may reach out to you. Thank you.

SEND YOUR STORIES HERE

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING

GSK - THE PAXIL FILES

SPECIAL THANKS TO DOUG BREMNER, CHRISTOPHER LANE AND HEALTHY SKEPTICISM FOR MAKING SOME OF THESE DOCUMENTS AVAILABLE

PAXIL/SEROXAT - GREATEST NUMBER OF SUICIDE ATTEMPTS


----

GSK PAXIL CASPPER DOCUMENT

----

GLAXOSMITHKLINE PROGRAM CALLED “PSYCHNET”

----

FOREWORD BY PAUL N. JENNER, DIRECTOR AND VICE PRESIDENT OF NEUROSCIENCE AND STRATEGIC PRODUCT DEVELOPMENT


----

SECTION 1: TOWARDS THE SECTION BILLION -- ALL SSRI'S ARE NOT THE SAME


----

SECTION 2: NEW INDICATIONS: SOCIAL ANXIETY DISORDER / SOCIAL PHOBIA


----

SECTION 3: ISSUES MANAGEMENT: MANAGING THE DISCONTINUATION ISSUE

----

"DURATION OF TREATMENT AND DEPRESSION: RELAPSE AND RECURRENCE RATES"

----

"PAXIL CR" PRODUCT MONOGRAPH


----

PAXIL LITIGATION DOCUMENTS


----

GSK's PAXIL.COM...STILL A WEALTH OF [DIS] INFORMATION


----

DOCUMENT RETENTION, LETTERS TO MINISTERS, LETTERS AND EMAILS ABOUT SEROXAT AND LIST OF FOI REQUESTS


----

MINUTES OF MEETING BETWEEN MHRA AND BOB FIDDAMAN


----

PRESS RELEASE: GSK INVESTIGATION CONCLUDES


----

MHRA INVESTIGATION INTO GLAXOSMITHKLINE/SEROXAT


----

GSK SEROXAT - LETTER TO GSK FROM MHRA


----

GSK SEROXAT - LETTER TO TRADE ASSOCIATIONS


----

SUMMARY OF REGULATORY ACTION


----

LETTER FROM GSK CHIEF MEDICAL OFFICER TO MHRA


----

MHRA RESPONSE TO LETTER FROM GSK CHIEF MEDICAL OFFICER


----

PAXIL STUDY 329 ALL OVER AGAIN?
Article By Bob Fiddaman


----

MARKET SENTINEL'S STAKEHOLDER ANALYSIS COMMISSIONED BY THE UK MHRA TO ASSESS PUBLIC DISCUSSION OF THE SEROXAT CONTROVERSY


----

KILKER V GLAXOSMITHKLINE COURT TRANSCRIPTS

----

PAXIL STUDY 329: PAROXETINE vs IMIPRAMINE vs PLACEBO IN ADOLESCENTS

Fid

ORDER THE PAPERBACK
'THE EVIDENCE, HOWEVER, IS CLEAR...THE SEROXAT SCANDAL' By Bob Fiddaman
SIGNED COPIES HERE OR UNSIGNED FROM CHIPMUNKA PUBLISHING